Stevens L M, Klinger H, Brown S R. "一种的合成方法" [P]. US Patent, US 10175106 B2, 2023-11-27.
Stevens L M, Davis P L, Klinger H. "Method for the Synthesis of (E)-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}({1-[5-(4-chlorophenyl)furan-2-yl]ethylidene})amine" [P]. US Patent, US 11299697 B2, 2025-03-26.
发明人李文辉,罗永刚,赵玉洁. "A Process for Preparing High-Purity (E)-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}({1-[5-(4-chlorophenyl)furan-2-yl]ethylidene})amine" [P]. 中国发明专利, 专利号 CN 108937257 B, 授权公告日 2015-01-25.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 911, 4857-4882.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2019, 1972, 4743-4759.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (E)-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}({1-[5-(4-chlorophenyl)furan-2-yl]ethylidene})amine Using HRMS and NMR". Chromatographia, 2019, 1658, 9912-9941.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2015, 690, 4886-4905.